Siderocalin
From Proteopedia
(Difference between revisions)
| Line 33: | Line 33: | ||
**[[3fw4]], [[3fw5]] – hScn NGAL (mutant) + catechol + Fe<br /> | **[[3fw4]], [[3fw5]] – hScn NGAL (mutant) + catechol + Fe<br /> | ||
**[[4gh7]], [[5n48]], [[5n47]] – hScn NGAL + fibronectin<br /> | **[[4gh7]], [[5n48]], [[5n47]] – hScn NGAL + fibronectin<br /> | ||
| + | **[[6s8v]] – hScn NGAL + CD98 heavy chain<br /> | ||
| + | **[[6sua]] – hScn NGAL (mutant) + CD98 heavy chain<br /> | ||
**[[5nkn]] – hScn NGAL + conchicine<br /> | **[[5nkn]] – hScn NGAL + conchicine<br /> | ||
**[[6gr0]] – hScn NGAL + petrobactin<br /> | **[[6gr0]] – hScn NGAL + petrobactin<br /> | ||
Revision as of 09:23, 3 November 2020
| |||||||||||
3D structures of siderocalin
Updated on 03-November-2020
>
References
- ↑ Hoette TM, Abergel RJ, Xu J, Strong RK, Raymond KN. The role of electrostatics in siderophore recognition by the immunoprotein Siderocalin. J Am Chem Soc. 2008 Dec 24;130(51):17584-92. doi: 10.1021/ja8074665. PMID:19053425 doi:http://dx.doi.org/10.1021/ja8074665
- ↑ Paragas N, Qiu A, Hollmen M, Nickolas TL, Devarajan P, Barasch J. NGAL-Siderocalin in kidney disease. Biochim Biophys Acta. 2012 Sep;1823(9):1451-8. doi: 10.1016/j.bbamcr.2012.06.014., Epub 2012 Jun 19. PMID:22728330 doi:http://dx.doi.org/10.1016/j.bbamcr.2012.06.014
- ↑ Holmes MA, Paulsene W, Jide X, Ratledge C, Strong RK. Siderocalin (Lcn 2) also binds carboxymycobactins, potentially defending against mycobacterial infections through iron sequestration. Structure. 2005 Jan;13(1):29-41. PMID:15642259 doi:10.1016/j.str.2004.10.009
